Activities of the Supervisory Board
During 2008 the Supervisory Board devoted considerable time to discussing the Company’s strategy. In particular the performance
and integration of recent acquisitions, such as Genlyte and Respironics, and the economic situation and impact thereof on
Philips and Vision 2010 were discussed extensively. The Supervisory Board also discussed the capital and financing structure
of the Philips Group and approved the sale of some or all of the Company's remaining shares in TSMC and LG Display. In June
the strategy of the Company and the sectors, including various risks and opportunities scenarios, were discussed during a
one and a half day meeting.
Other discussion topics included:
- financial performance of the Philips Group and the sectors
- status of merger and acquisition projects
- rebranding of products of acquired companies
- management agenda of the Board of Management and especially the steps taken to deal with the unsatisfactory EBITA margins
in the TV business
- remuneration policy
- management development and succession planning
- evaluation of the Board of Management and its members
- geographic performance and growth opportunities in Emerging Markets and particularly the shift of resources from mature to
emerging markets
- the shift of R&D spend from existing product categories to new product categories
- the situation and improvement measures at some businesses that did not perform according to plan
- the results of the Employee Engagement Score and the implementation and impact of the Net Promoter Score
- financial scenarios for 2009
- the situation at Philips Pension Fund in the Netherlands
- restructuring in various sectors
- the system of internal business controls and risk management
- the investigations into possible anticompetitive activities in the CRT industry.
The Supervisory Board visited Lighting and Healthcare to further familiarize itself with the business and the respective management
teams. Also, the yearly Corporate Research Exhibition was visited, at which event the latest technological projects and inventions
of the Company are presented. The members spent two days in Boston/Andover where they discussed the Philips businesses in
the United States of America and visited, amongst others, the head office of Healthcare and attended presentations of various
businesses, including the recently acquired business of Respironics, Colour Kinetics, Genlyte, Emergin and VISICU. Finally,
several members of the Supervisory Board also attended external training programs, which are often dedicated to specific topics.
|